150 places available

Conference 2020

NOVEL WAYS TO FIGHT PATHOGENS

Corso Umberto I 33 - 28838 Stresa
Lake Maggiore, ITALY
C/O Hotel La Palma

March 29 to April 1, 2020

Due to the large request received up to now, the early bird registration time is prolonged. You can be an early bird participant until the 31st of January 2020!

Conference Information

The “Immunotherapy for Infectious Diseases Conference” brings together academia, small biotech, big pharma and regulatory bodies invested in the discovery of novel therapeutic strategies.

Infectious diseases remain a leading cause of morbidity and mortality worldwide necessitating novel and innovative therapeutics. Current and future challenges range from neglected diseases affecting the poorest countries to antimicrobial resistant pathogens in modern hospitals; from rare but deadly infections affecting few to the threat of potential global pandemics; from pathogens reaching new geographical areas due to climate changes to disease reemerging due to lack of vaccination coverage.

The ability of the human immune system to fight pathogens can be exploited for effective therapeutic strategies. Recombinant and further engineered antibodies can be used as active ingredients, as targeting agents to selectively deliver drugs or to establish novel vaccination strategies. Bringing a novel therapy to the patients requires the combined effort of several players, all of which are brought together in the “Immunotherapy for Infectious Diseases Conference”, with world high caliber speakers and participants.

The congress is organized in the USA and Europe in alternating years with the aim to serve as a forum to exchange ideas and foster cross-disciplinary collaborations.

We have assembled an exciting program for the conference that features keynote seminars from international experts in the field, talks from both academia and industry as well as presentations on novel therapeutic techniques for immunotherapy. The conference program also contains poster sessions.

The Immunotherapy for Infectious Diseases conference will be held on March 29 to April 1, 2020 at C/O Hotel La Palma.

Public

Young scientists & Academics

  • Includes all meals!
  • Comfortable Seat
  • Coffee Break
  • Poster session
  • Certificate
  • Registration will NOT includes the cost of accommodation
Register
Private

Private

  • Includes all meals!
  • Comfortable Seat
  • Coffee Break
  • Poster session
  • Certificate
  • Registration will NOT includes the cost of accommodation
Register

Event Schedule

MONDAY MARCH 30, 2019
SESSION 1 - ANTIBODY-BASED DRUG DEVELOPMENT
SESSION 2 - NANOMEDICINE AGAINST INFECTIOUS DISEASES;
SESSION 3 - IMMUNOTHERAPY AGAINST EMERGING INFECTIOUS DISEASES

TUESDAY MARCH 31, 2019
SESSION 4 - IMMUNOTHERAPY AGAINST VIRAL INFECTIONS;
SESSION 5 - IMMUNOTHERAPY AGAINST BACTERIAL INFECTIONS;

WEDNESDAY APRIL 1, 2019
SESSION 6 - PRODUCTION AND REGULATORY CHALLENGES;
SESSION 7 - 3RS PRINCIPLES IN BIOTECHNOLOGICAL AND MEDICAL APPLICATIONS
CONCLUSIONS AND REMARKS

Speakers and sessions

SESSION 1 - ANTIBODY-BASED DRUG DEVELOPMENT

Keynote Speaker: Davide Corti, Humabs BioMed SA a subsidiary of Vir Biotechnology
Andreas Laustsen, Technical University of Denmark, Denmark
VIR speaker, Vir Biotechnology
Anna Codina, Bruker Biospin - from BRUKER
Bernard Vanhove, CSO, Xenothera
Selected abstracts for oral presentations
Poster Session

Speakers and sessions

SESSION 2 - NANOMEDICINE AGAINST INFECTIOUS DISEASES

Donata Medaglini, University of Siena, Italy
Jennifer Grossman, National Institute of Health, USA

Speakers and sessions

SESSION 3 - IMMUNOTHERAPY AGAINST EMERGING INFECTIOUS DISEASES

Keynote Speaker: Antonio Lanzavecchia, IRB, Switzerland
Lisa Purcell from REGENERON
Luca Varani, IRB, Switzerland
Keynote Speaker: Man-Wah Tan, Genentech, USA

Sponsors

This event is possible thanks to the contribution of

Platinum Sponsor
Preclinics
Platinum Sponsor
Vir Biotechnology
Platinum Sponsor
YUMAB
Silver Sponsor
HOEPLI
Basic Sponsor
Bioidea

PREVIOUS CONFERENCE:
November 12-14th, 2018, Galveston, Texas, USA